CERTARA INC. - COMMON STOCK

Certara Reports Third Quarter 2024 Financial Results

06 ноя 2024 16:15:01 Источник Nasdaq GlobeNewswire

Certara to Participate in the Stephens Annual Investment Conference

28 окт 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara Appoints John Reynders as New Independent Board Member

16 окт 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

09 окт 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara Completes Acquisition of Chemaxon

02 окт 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara’s Simcyp Consortium Celebrates 25th Anniversary

24 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

18 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

21 авг 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara Launches Phoenix™ Version 8.5 Drug Development Software

15 авг 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara Reports Second Quarter 2024 Financial Results

06 авг 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

09 июл 2024 16:45:00 Источник Nasdaq GlobeNewswire

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

02 июл 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

17 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire

Certara to Participate in the Jefferies Global Healthcare Conference

29 май 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara Appoints New Chief Human Resources Officer & General Counsel

21 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Certara Reports First Quarter 2024 Financial Results

07 май 2024 16:15:00 Источник Nasdaq GlobeNewswire

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

16 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Certara Reports Fourth Quarter 2023 Financial Results

29 фев 2024 16:10:01 Источник Nasdaq GlobeNewswire

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

01 фев 2024 16:30:00 Источник Nasdaq GlobeNewswire

Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

13 дек 2023 16:30:00 Источник Nasdaq GlobeNewswire